CalciMedica is trading 10.4% up at $0.82 as the stock continues to stabilize following sharp FDA-related volatility over the past several sessions.
- The upward move appears driven by ongoing trading dynamics and a recovery from prior price swings, as there have been no fresh company-specific announcements this morning.
- Sentiment is further supported by a risk-on broader market backdrop, with major U.S. indices all gaining more than 1%.